Profiel
Sladjana Obadovic currently works as the Head of Investment Controlling at Abacus alpha GmbH.
Actieve functies van Sladjana Obadovic
| Bedrijven | Functie | Begin |
|---|---|---|
Abacus alpha GmbH
Abacus alpha GmbH Investment ManagersFinance Abacus alpha is an active manager which provides financing for restructuring, insolvencies, successions (buyouts and MBOs), secondary transactions, as well as for early stage and growth capital requirements. It invests in both young companies and established medium-sized enterprises located in Europe, with revenues between EUR 3 million and EUR 50 million. It targets industrial, commercial and service companies which operate in a variety of areas such as industry 4.0, energy & energy efficiency, clean/green technologies, water & waste water, and the like. The company, however, does not focus on companies in the fields of B2C, pharmaceuticals, biotechnology, and chemicals. With a typical investment size between EUR 2 and 30 million and a transaction size between EUR 1 million and 10 million, the firm is open to making both minority and majority investments. | Private Equity Investor | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Abacus alpha GmbH
Abacus alpha GmbH Investment ManagersFinance Abacus alpha is an active manager which provides financing for restructuring, insolvencies, successions (buyouts and MBOs), secondary transactions, as well as for early stage and growth capital requirements. It invests in both young companies and established medium-sized enterprises located in Europe, with revenues between EUR 3 million and EUR 50 million. It targets industrial, commercial and service companies which operate in a variety of areas such as industry 4.0, energy & energy efficiency, clean/green technologies, water & waste water, and the like. The company, however, does not focus on companies in the fields of B2C, pharmaceuticals, biotechnology, and chemicals. With a typical investment size between EUR 2 and 30 million and a transaction size between EUR 1 million and 10 million, the firm is open to making both minority and majority investments. | Finance |
















